Alerts will be sent to your verified email
Verify Email
ADVENZYMES
Positive for this company
Neutral for this company
Negative for this company
Insufficient data to analyse
Advanced Enzymes Technologies Limited is the largest Indian enzyme company focusing on research, development, and manufacturing of enzymes and probiotics. Their aim is to provide side-effect free healthcare solutions, improve animal nutrition, and promote enzyme-based industrial processes.
Advanced Enzyme major competitors are Fermenta Biotech, Concord Biotech, Biocon, Gufic Biosciences, Orchid Pharma, Unichem Lab, Guj. Themis Biosyn.
Market Cap of Advanced Enzyme is ₹3,798 Crs.
While the median market cap of its peers are ₹3,999 Crs.
Advanced Enzyme seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annual Report | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | ||
| Earnings Release | May Aug | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Jun Sep | Mar Jun | Mar Jun Sep | Dec | Sep Dec | ||||||||
| Investor Presentation | May Aug | Mar Jun Sep Dec | Mar Jun Sep Dec | Feb Mar May Jun Aug Sep Dec | Mar May Sep Dec | Mar Jun Sep | Mar Jun Sep Dec | Mar Jun Sep | Mar Sep Dec | Sep Dec | ||||||||
| Conference Call | Mar Aug | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Sep Dec | Mar Jun Sep Dec | Mar Jun Sep | Mar Jun Sep Dec | Sep Dec | ||||||||
|
Conference Call SummaryCon Call Summary
Powered by Gemini
|
